Axel Muendlein
Axel Muendlein publishes mostly in Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Surgery, on topics such as Cardiovascular Disease and Adiposity, Lipoproteins and Cardiovascular Health and Diabetes, Cardiovascular Risks, and Lipoproteins.
- World rank
- #7,529,372 of 7,710,434 ranked researchers
- Rank in Liechtenstein
- #152 of 161
- Works
- 434
- Citations
- 2.4k
- Citations per work
- 5.6
What does Axel Muendlein research?
Axel Muendlein's work is mostly in Medicine (52%), Biochemistry, Genetics and Molecular Biology (7%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences22551.8%
- Medicine22551.8%
- Everything else17941.3%
- Life Sciences306.9%
- 1Cardiology and Cardiovascular Medicine17% of their works
- 2Endocrinology, Diabetes and Metabolism12% of their works
- 3Surgery10% of their works
- 4Molecular Biology7% of their works
- 5Epidemiology7% of their works
- 6Physiology5% of their works
Research topics
- Cardiovascular Disease and Adiposity
- Lipoproteins and Cardiovascular Health
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Liver Disease Diagnosis and Treatment
- Peripheral Artery Disease Management
- Adipokines, Inflammation, and Metabolic Diseases
- Diabetes Treatment and Management
- Cardiovascular Function and Risk Factors
Which keywords describe Axel Muendlein's research?
The keywords of their largest research topics: Obesity, Atherosclerosis, Cardiovascular Disease, Insulin Resistance, Metabolic Syndrome, Inflammation, C-Reactive Protein and Diabetes.
- Echocardiography
- Glucose Control
- Adipose Tissue
- Peripheral Arterial Disease
- NASH
- Lifestyle Intervention
- Heart Failure
- Statins
- Perivascular Adipose Tissue
- Diabetes
- Inflammation
- Insulin Resistance
- Atherosclerosis
- Obesity
- Cardiovascular Disease
- Metabolic Syndrome
- C-Reactive Protein
- Epicardial Fat
- Cholesterol-lowering
- Type 2 Diabetes
- Glucose Metabolism
- NAFLD
- Guidelines
- Adipokines
- Cardiovascular Outcomes
- Chamber Quantification
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 26 words, with their numbers
- Obesity1594 topics
- Atherosclerosis1403 topics
- Cardiovascular Disease1363 topics
- Insulin Resistance1073 topics
- Metabolic Syndrome1073 topics
- Inflammation892 topics
- C-Reactive Protein832 topics
- Diabetes772 topics
- Epicardial Fat631 topic
- Perivascular Adipose Tissue631 topic
- Cholesterol-lowering571 topic
- Statins571 topic
- Type 2 Diabetes512 topics
- Heart Failure482 topics
- Glucose Metabolism471 topic
- Lifestyle Intervention471 topic
- NAFLD341 topic
- NASH341 topic
- Guidelines301 topic
- Peripheral Arterial Disease301 topic
- Adipokines261 topic
- Adipose Tissue261 topic
- Cardiovascular Outcomes251 topic
- Glucose Control251 topic
- Chamber Quantification231 topic
- Echocardiography231 topic
Where does Axel Muendlein work?
Axel Muendlein's main affiliation in the publication record is Private University in the Principality of Liechtenstein, Liechtenstein.
How many publications and citations does Axel Muendlein have?
OpenAlex counts 434 works and 2,444 citations for Axel Muendlein, an h-index of 29, ranking #7,529,372 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Axel Muendlein. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.